Skip to main content
SpringerLink
Log in

Gastrointestinal Infections After Solid Organ or Hematopoietic Cell Transplantation

  • Chapter
  • First Online:
Transplant Infections

Abstract

The gastrointestinal tract is a common site of infection in patients who are immunosuppressed following either solid organ (SOT) or hematopoietic cell transplantation (HCT). Prophylactic regiments and screening have decreased the rate of infections, but despite these advances viruses, fungi, and bacteria continue to be a major cause of morbidity. In this chapter we first present a transplant-specific approach to gastrointestinal infections followed by a problem-oriented approach to gastrointestinal symptoms after transplant.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Kathuria P, Sakhuja V, Gupta KL, Jha V, Kochhar R, Joshi K, et al. Gastrointestinal complications after renal transplantation. 10 year data from a North Indian transplant center. ASAIO J. 1995;41(3):M698–703.

    CAS  PubMed  Google Scholar 

  2. Helderman JH, Goral S. Gastrointestinal complications of transplant immunosuppression. J Am Soc Nephrol. 2002;13(1): 277–87.

    PubMed  Google Scholar 

  3. Logan AJ, Morris-Stiff GJ, Bowrey DJ, Jurewicz WA. Upper gastrointestinal complications after renal transplantation: a 3-yr sequential study. Clin Transplant. 2002;16(3):163–7.

    PubMed  Google Scholar 

  4. Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19(1):3–26.

    PubMed  Google Scholar 

  5. San Juan R, Aguado JM, Lumbreras C, Fortun J, Munoz P, Gavalda J, et al. RESITRA Network of the spanish study group of infection in transplantation. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation. Clin Infect Dis. 2008; 47(7):875–82.

    Google Scholar 

  6. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation. 1996;61(7): 1029–37.

    Google Scholar 

  7. Humar A, Snydman D. Cytomegalovirus in solid organ transplant recipients. Am J Transplant. 2009;9 Suppl 4:S78–86.

    PubMed  Google Scholar 

  8. Beam E, Razonable RR. Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment. Curr Infect Dis Rep. 2012;14(6):633–41.

    PubMed  Google Scholar 

  9. Snydman DR, Limaye AP, Potena L, Zamora MR. Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. Transplant Proc. 2011;43(3 Suppl):S1–7.

    PubMed  Google Scholar 

  10. Smith C, Khanna R. Immune regulation of human herpesviruses and its implications for human transplantation. Am J Transplant. 2013;13 Suppl 3:9–23.

    CAS  PubMed  Google Scholar 

  11. Fishman JA. Overview: cytomegalovirus and the herpesviruses in transplantation. Am J Transplant. 2013;13 Suppl 3:1–8.

    CAS  PubMed  Google Scholar 

  12. Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2010;10(1):157–61.

    CAS  PubMed  Google Scholar 

  13. Tilsed JV, Morgan JD, Veitch PS, Donnelly PK. Reactivation of duodenal cytomegalovirus infection mimicking a transplant lymphoma. Transplantation. 1992;54:945–6.

    CAS  PubMed  Google Scholar 

  14. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 2010;89(7):779–95.

    PubMed  Google Scholar 

  15. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96(4):333–60.

    CAS  PubMed  Google Scholar 

  16. Hodson EM, Ladhani M, Webster AC, Strippoli GF, Craig JC. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2013;2:CD003774.

    Google Scholar 

  17. Witzke O, Hauser IA, Bartels M, Wolf G, Wolters H, Nitschke M, et al. Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial. Transplantation. 2012;93(1):61–8.

    CAS  PubMed  Google Scholar 

  18. Mengelle C, Rostaing L, Weclawiak H, Rossignol C, Kamar N, Izopet J. Prophylaxis versus pre‐emptive treatment for prevention of cytomegalovirus infection in CMV‐seropositive orthotopic liver‐transplant recipients. J Med Virol. 2015;87(5): 836–44.

    PubMed  Google Scholar 

  19. Snydman DR. Putting the IMPACT study into perspective: should CMV prophylaxis be extended to 6 months for high risk transplants? Am J Transplant. 2011;11(1):6–7.

    CAS  PubMed  Google Scholar 

  20. Gerna G, Lilleri D, Furione M, Baldanti F. Management of human cytomegalovirus infection in transplantation: validation of virologic cut-offs for preemptive therapy and immunological cut-offs for protection. New Microbiol. 2011;34(3): 229–54.

    PubMed  Google Scholar 

  21. Zuckerman RA, Limaye AP. Varicella zoster virus (VZV) and herpes simplex virus (HSV) in solid organ transplant patients. Am J Transplant. 2013;13 Suppl 3:55–66.

    CAS  PubMed  Google Scholar 

  22. Fiddian P, Sabin CA, Griffiths PD. Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation. J Infect Dis. 2002;186 Suppl 1:S110–5.

    CAS  PubMed  Google Scholar 

  23. Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013;13 Suppl 3:41–54.

    CAS  PubMed  Google Scholar 

  24. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet. 2000;355(9218):1886–7.

    CAS  PubMed  Google Scholar 

  25. Agraharkar ML, Cinclair RD, Kuo YF, Daller JA, Shahinian VB. Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kidney Int. 2004;66(1):383–9.

    PubMed  Google Scholar 

  26. Tremblay F, Fernandes M, Habbab F, deB Edwardes MD, Loertscher R, Meterissian S. Malignancy after renal transplantation: incidence and role of type of immunosuppression. Ann Surg Oncol. 2002;9(8):785–8.

    PubMed  Google Scholar 

  27. Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer. 2003;89(7):1221–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Razonable RR. Human herpesviruses 6, 7 and 8 in solid organ transplant recipients. Am J Transplant. 2013;13 Suppl 3:67–78.

    CAS  PubMed  Google Scholar 

  29. Lee LY, Ison MG. Diarrhea caused by viruses in transplant recipients. Transpl Infect Dis. 2014;16(3):347–58.

    CAS  PubMed  Google Scholar 

  30. Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med. 2013;369(13):1227–36.

    CAS  PubMed  Google Scholar 

  31. Echenique IA, Penugonda S, Stosor V, Ison MG, Angarone MP. Diagnostic yields in solid organ transplant recipients admitted with diarrhea. Clin Infect Dis. 2015;60(5):729–37.

    CAS  PubMed  Google Scholar 

  32. Tsapepas DS, Martin ST, Miao J, Shah SA, Scheffert J, Fester K, et al. Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center. Diagn Microbiol Infect Dis. 2015;81(4):299–304.

    PubMed  Google Scholar 

  33. Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM, et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis. 2008;197(3):435–8.

    PubMed  Google Scholar 

  34. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology. 2009;136(6):1913–24.

    CAS  PubMed  Google Scholar 

  36. Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422–31.

    CAS  PubMed  Google Scholar 

  37. Surawicz CM, Alexander J. Treatment of refractory and recurrent Clostridium difficile infection. Nat Rev Gastroenterol Hepatol. 2011;8(6):330–9.

    CAS  PubMed  Google Scholar 

  38. Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109(7):1065–71.

    PubMed  PubMed Central  Google Scholar 

  39. Mittal C, Miller N, Meighani A, Hart BR, John A, Ramesh M. Fecal microbiota transplant for recurrent Clostridium difficile infection after peripheral autologous stem cell transplant for diffuse large B-cell lymphoma. Bone Marrow Transplant. 2015;50(7):1010.

    CAS  PubMed  Google Scholar 

  40. Goldberg EJ, Bhalodia S, Jacob S, Patel H, Trinh KV, Varghese B, et al. Clostridium difficile infection: a brief update on emerging therapies. Am J Health Syst Pharm. 2015;72(12): 1007–12.

    CAS  PubMed  Google Scholar 

  41. Gerding DN, Meyer T, Lee C, Cohen SH, Murthy UK, Poirier A, et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA. 2015;313(17): 1719–27.

    PubMed  Google Scholar 

  42. Espinosa-Aguilar L, Forrest GN. Candidiasis in solid organ transplantation. Infectious Disease and Antimicrobial Agents. www.antimicrobe.org/new/t06_ew.html.

  43. Farmakiotis D, Kontoyiannis DP. Emerging issues with diagnosis and management of fungal infections in solid organ transplant recipients. Am J Transplant. 2015:n/a-n/a.

    Google Scholar 

  44. Gavaldà J, Meije Y, Fortún J, Roilides E, Saliba F, Lortholary O, et al. Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect. 2014;20:27–48.

    PubMed  Google Scholar 

  45. Gumbo T, Hobbs RE, Carlyn C, Hall G, Isada CM. Microsporidia infection in transplant patients. Transplantation. 1999;67(3):482–4.

    CAS  PubMed  Google Scholar 

  46. DeVault GA, King JW, Rohr MS, Landreneau MD, Brown ST, McDonald JC. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis. 1990;12(4):653–71.

    PubMed  Google Scholar 

  47. Sarkio S, Halme L, Kyllonen L, Salmela K. Severe gastrointestinal complications after 1,515 adult kidney transplantations. Transpl Int. 2004;17(9):505–10.

    PubMed  Google Scholar 

  48. Gil-Vernet S, Amado A, Ortega F, Alarcon A, Bernal G, Capdevila L, et al. Gastrointestinal complications in renal transplant recipients: MITOS study. Transplant Proc. 2007;39(7):2190–3.

    CAS  PubMed  Google Scholar 

  49. Ponticelli C, Passerini P. Gastrointestinal complications in renal transplant recipients. Transpl Int. 2005;18(6):643–50.

    PubMed  Google Scholar 

  50. Andreoni KA, Pelletier RP, Elkhammas EA, Davies EA, Bumgardner GL, Henry ML, et al. Increased incidence of gastrointestinal surgical complications in renal transplant recipients with polycystic kidney disease. Transplantation. 1999; 67(2):262–6.

    CAS  PubMed  Google Scholar 

  51. Dee SL, Butt K, Ramaswamy G. Intestinal ischemia. Arch Pathol Lab Med. 2002;126(10):1201–4.

    PubMed  Google Scholar 

  52. Lowell JA, Stratta RJ, Taylor RJ, Bynon JS, Larsen JL, Nelson NL. Cholelithiasis in pancreas and kidney transplant recipients with diabetes. Surgery. 1993;114(4):858–63.

    CAS  PubMed  Google Scholar 

  53. Moudgil A, Germain BM, Nast CC, Toyoda M, Strauss FG, Jordan SC. Ureteritis and cholecystitis: two unusual manifestations of cytomegalovirus disease in renal transplant recipients. Transplantation. 1997;64(7):1071–3.

    CAS  PubMed  Google Scholar 

  54. Badalamenti S, DeFazio C, Castelnovo C, Sangiovanni A, Como G, De Vecchi A, et al. High prevalence of silent gallstone disease in dialysis patients. Nephron. 1994;66(2): 225–7.

    CAS  PubMed  Google Scholar 

  55. Berger N, Wirmsberger R, Kafka R, Margreiter C, Ebenbichler C, Stelzmueller I, et al. Infectious complications following 72 consecutive enteric-drained pancreas transplants. Transpl Int. 2006;19(7):549–57.

    CAS  PubMed  Google Scholar 

  56. Toupance O, Bouedjoro-Camus MC, Carquin J, Novella JL, Lavaud S, Wynckel A, et al. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses. Transpl Int. 2000;13(6):413–9.

    CAS  PubMed  Google Scholar 

  57. Kunzle N, Petignat C, Francioli P, Vogel G, Seydoux C, Corpataux JM, et al. Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidity. Transpl Infect Dis. 2000;2(3):118–26.

    CAS  PubMed  Google Scholar 

  58. Slifkin M, Tempesti P, Poutsiaka DD, Snydman DR. Late and atypical cytomegalovirus disease in solid-organ transplant recipients. Clin Infect Dis. 2001;33(7):E62–8.

    CAS  PubMed  Google Scholar 

  59. Rayes N, Seehofer D, Kahl A, Kokott S, Pratschke J, Frei U, et al. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis. Transpl Int. 2007;20(11):974–81.

    PubMed  Google Scholar 

  60. Boudreault AA, Xie H, Rakita RM, Scott JD, Davis CL, Boeckh M, et al. Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis. Transpl Infect Dis. 2011;13(3):244–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Ardalan MR, Etemadi J, Somi MH, Ghafari A, Ghojazadeh M. Upper gastrointestinal bleeding during the first month after renal transplantation in the mycophenolate mofetil era. Transplant Proc. 2009;41(7):2845–7.

    CAS  PubMed  Google Scholar 

  62. Sarkio S, Rautelin H, Kyllonen L, Honkanen E, Salmela K, Halme L. Should helicobacter pylori infection be treated before kidney transplantation? Nephrol Dial Transplant. 2001;16(10):2053–7.

    CAS  PubMed  Google Scholar 

  63. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741–51. see comments. [Review] [80 refs].

    CAS  PubMed  Google Scholar 

  64. Metge S, Van Nhieu JT, Dahmane D, Grimbert P, Foulet F, Sarfati C, et al. A case of Enterocytozoon bieneusi infection in an HIV-negative renal transplant recipient. Eur J Clin Microbiol Infect Dis. 2000;19(3):221–3.

    CAS  PubMed  Google Scholar 

  65. Mayoral JL, Loeffler CM, Fasola CG. Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations. Arch Surg. 1991;126: 202–6.

    CAS  PubMed  Google Scholar 

  66. Frankel AH, Barker F, Williams G, Benjamin IS, Lechler R, Rees AJ. Neutropenic colitis in a renal transplant patient. Transplantation. 1991;52:913–4.

    CAS  PubMed  Google Scholar 

  67. Roncoroni AJ, Gomez MA, Mera J, Cagnoni P, Michel MD. Cryptosporidium infection in renal transplant patients. (Lett). J Infect Dis. 1989;160:559.

    CAS  PubMed  Google Scholar 

  68. Altiparmak MR, Trablus S, Pamuk ON, Apaydin S, Sariyar M, Ozturk R, et al. Diarrhoea following renal transplantation. Clin Transplant. 2002;16(3):212–6.

    PubMed  Google Scholar 

  69. Tavakoli A, Liong S. Pancreatic transplant in diabetes. Adv Exp Med Biol. 2012;771:420–37.

    PubMed  Google Scholar 

  70. Tam N, Zhang C, Lin J, Wu C, Deng R, Liao B, et al. Simultaneous pancreas and kidney transplantation for liver transplant recipients with diabetes and uremia. Clin Res Hepatol Gastroenterol. 2015;39(3):399–404.

    PubMed  Google Scholar 

  71. Herrero-Martinez JM, Lumbreras C, Manrique A, San-Juan R, Garcia-Reyne A, Lopez-Medrano F, et al. Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation. Clin Microbiol Infect. 2013;19(12):1132–9.

    CAS  PubMed  Google Scholar 

  72. Sterling RK. Management of gastrointestinal disease in liver transplant recipients. Gastrointest Endosc Clin N Am. 2001;11(1):185–97.

    CAS  PubMed  Google Scholar 

  73. Verdonk RC, Buis CI, Porte RJ, Haagsma EB. Biliary complications after liver transplantation: a review. Scand J Gastroenterol Suppl. 2006;243:89–101.

    Google Scholar 

  74. Pedersen M, Seetharam A. Infections after orthotopic liver transplantation. J Clin Exp Hepatol. 2014;4(4):347–60.

    PubMed  PubMed Central  Google Scholar 

  75. Kim SI. Bacterial infection after liver transplantation. World J Gastroenterol. 2014;20(20):6211–20.

    PubMed  PubMed Central  Google Scholar 

  76. Chow JK, Werner BG, Ruthazer R, Snydman DR. Increased serum iron levels and infectious complications after liver transplantation. Clin Infect Dis. 2010;51(3):e16–23.

    CAS  PubMed  Google Scholar 

  77. Milan A, Sampaio AM, Guardia AC, Pavan CR, Andrade PD, Bonon SH, et al. Identification of bacterial infections and clinical manifestation associated with cytomegalovirus in liver transplantation patients. Transplant Proc. 2013;45(3):1130–2.

    CAS  PubMed  Google Scholar 

  78. Bosch W, Heckman MG, Diehl NN, Shalev JA, Pungpapong S, Hellinger WC. Association of cytomegalovirus infection and disease with death and graft loss after liver transplant in high-risk recipients. Am J Transplant. 2011;11(10):2181–9.

    CAS  PubMed  Google Scholar 

  79. Mukhtar A, Abdelaal A, Hussein M, Dabous H, Fawzy I, Obayah G, et al. Infection complications and pattern of bacterial resistance in living-donor liver transplantation: a multicenter epidemiologic study in Egypt. Transplant Proc. 2014;46(5):1444–7.

    CAS  PubMed  Google Scholar 

  80. Antunes M, Teixeira A, Fortuna P, Moya B, Martins A, Bagulho L, et al. Infections after liver transplantation: a retrospective, single-center study. Transplant Proc. 2015;47(4):1019–24.

    CAS  PubMed  Google Scholar 

  81. Kawecki D, Pacholczyk M, Lagiewska B, Sawicka-Grzelak A, Durlik M, Mlynarczyk G, et al. Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility. Transplant Proc. 2014;46(8):2777–81.

    CAS  PubMed  Google Scholar 

  82. Esfeh JM, Hanouneh IA, Koval CE, Kovacs C, Dalal DS, Ansari-Gilani K, et al. Impact of pretransplant rifaximin therapy on early post-liver transplant infections. Liver Transpl. 2014;20(5):544–51.

    PubMed  Google Scholar 

  83. Sanchez CL, Len O, Gavalda J, Bilbao I, Castells L, Gelabert MA, et al. Liver biopsy-related infection in liver transplant recipients: a current matter of concern? Liver Transpl. 2014;20(5):552–6.

    PubMed  Google Scholar 

  84. Wong NA, Bathgate AJ, Bellamy CO. Colorectal disease in liver allograft recipients—a clinicopathological study with follow-up. Eur J Gastroenterol Hepatol. 2002;14(3):231–6.

    PubMed  Google Scholar 

  85. Razonable RR. Cytomegalovirus infection after liver transplantation: current concepts and challenges. World J Gastroenterol. 2008;14(31):4849–60.

    PubMed  PubMed Central  Google Scholar 

  86. Arthurs SK, Eid AJ, Pedersen RA, Dierkhising RA, Kremers WK, Patel R, et al. Delayed-onset primary cytomegalovirus disease after liver transplantation. Liver Transpl. 2007;13(12): 1703–9.

    PubMed  Google Scholar 

  87. Jain A, Orloff M, Kashyap R, Lansing K, Betts R, Mohanka R, et al. Does valganciclovir hydrochloride (Valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients? Transplant Proc. 2005;37(7):3182–6.

    CAS  PubMed  Google Scholar 

  88. Vivarelli M, De Ruvo N, Lazzarotto T, Bellusci R, Landini MP, Varani S, et al. Abstension from treatment of low-level pp 65 cytomegalovirus antigenemia after liver transplantation: a prospective study. Transplantation. 2000;70(8):1183–7.

    CAS  PubMed  Google Scholar 

  89. Lautenschlager I, Halme L, Hockerstedt K, Krogerus L, Taskinen E. Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations. Transpl Infect Dis. 2006;8(1):21–30.

    CAS  PubMed  Google Scholar 

  90. Hoffman JA. Adenoviral disease in pediatric solid organ transplant recipients. Pediatr Transplant. 2006;10(1):17–25.

    CAS  PubMed  Google Scholar 

  91. Hierholzer JC. Adenoviruses in the immunocompromised host. Clin Microbiol Rev. 1992;5:262–74.

    CAS  PubMed  PubMed Central  Google Scholar 

  92. McLaughlin GE, Delis S, Kashimawo L, Cantwell GP, Mittal N, Cirocco RE, et al. Adenovirus infection in pediatric liver and intestinal transplant recipients: utility of DNA detection by PCR. Am J Transplant. 2003;3(2):224–8.

    PubMed  Google Scholar 

  93. Sganga G, Bianco G, Frongillo F, Lirosi MC, Nure E, Agnes S. Fungal infections after liver transplantation: incidence and outcome. Transplant Proc. 2014;46(7):2314–8.

    CAS  PubMed  Google Scholar 

  94. Raghuram A, Restrepo A, Safadjou S, Cooley J, Orloff M, Hardy D, et al. Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007). Liver Transpl. 2012;18(9):1100–9.

    PubMed  Google Scholar 

  95. Shi S-H, Lu A-W, Shen Y, Jia C-K, Wang W-L, Xie H-Y, et al. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation. Chin Med J (Engl). 2008;121(7):625–30.

    PubMed  Google Scholar 

  96. Alexander J, Limaye AP, Ko CW, Bronner MP, Kowdley K. Association of hepatic iron overload with invasive fungal infection in liver transplant recipients. Liver Transpl. 2006;12:1799–804.

    PubMed  Google Scholar 

  97. Saliba F, Pascher A, Cointault O, Laterre PF, Cervera C, De Waele JJ, et al. Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients. Clin Infect Dis. 2015;60(7):997–1006.

    CAS  PubMed  Google Scholar 

  98. Winston DJ, Limaye AP, Pelletier S, Safdar N, Morris MI, Meneses K, et al. Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients. Am J Transplant. 2014;14(12):2758–64.

    CAS  PubMed  Google Scholar 

  99. Maurer JR. The spectrum of colonic complications in a lung transplant population. Ann Transplant. 2000;5(3):54–7.

    CAS  PubMed  Google Scholar 

  100. Bravo C, Gispert P, Borro JM, de la Torre M, Cifrian Martinez JM, Fernandez Rozas S, et al. Prevalence and management of gastrointestinal complications in lung transplant patients: MITOS study group. Transplant Proc. 2007;39(7):2409–12.

    CAS  PubMed  Google Scholar 

  101. Diaz B, Gonzalez Vilchez F, Almenar L, Delgado JF, Manito N, Paniagua MJ, MITOS Study Group, et al. Gastrointestinal complications in heart transplant patients: MITOS study. Transplant Proc. 2007;39:2397–400.

    CAS  PubMed  Google Scholar 

  102. Hadjiliadis D, Duane Davis R, Steele MP, Messier RH, Lau CL, Eubanks SS, et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant. 2003;17(4):363–8.

    PubMed  Google Scholar 

  103. Young LR, Hadjiliadis D, Davis RD, Palmer SM. Lung transplantation exacerbates gastroesophageal reflux disease. Chest. 2003;124(5):1689–93.

    PubMed  Google Scholar 

  104. Berkowitz N, Schulman LL, McGregor C, Markowitz D. Gastroparesis after lung transplantation. Potential role in postoperative respiratory complications. Chest. 1995;108(6):1602–7.

    CAS  PubMed  Google Scholar 

  105. Sodhi SS, Guo JP, Maurer AH, O'Brien G, Srinivasan R, Parkman HP. Gastroparesis after combined heart and lung transplantation. J Clin Gastroenterol. 2002;34(1):34–9.

    CAS  PubMed  Google Scholar 

  106. Verleden GM, Besse T, Maes B. Successful conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient. Transplantation. 2002;73(12):1974–6.

    PubMed  Google Scholar 

  107. Lau CL, Palmer SM, Howell DN, McMahon R, Hadjiliadis D, Gaca J, et al. Laparoscopic antireflux surgery in the lung transplant population. Surg Endosc. 2002;16(12):1674–8.

    CAS  PubMed  Google Scholar 

  108. Davis Jr RD, Lau CL, Eubanks S, Messier RH, Hadjiliadis D, Steele MP, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg. 2003;125(3):533–42.

    PubMed  Google Scholar 

  109. Curling TB. On acute ulceration of the duodenum in cases of burn. Med Chir Trans. 1842;25:260–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  110. Spirt MJ. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther. 2004;26(2):197–213.

    PubMed  Google Scholar 

  111. Bridges ND, Spray TL, Collins MH, Bowles NE, Towbin JA. Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg. 1998;116(4): 617–23.

    CAS  PubMed  Google Scholar 

  112. Kemnitz J, Cremer J, Gebel M, Uysal A, Haverich A, Georgii A. T-cell lymphoma after heart transplantation. Am J Clin Pathol. 1990;94:95–101.

    CAS  PubMed  Google Scholar 

  113. Gilljam M, Chaparro C, Tullis E, Chan C, Keshavjee S, Hutcheon M. GI complications after lung transplantation in patients with cystic fibrosis. Chest. 2003;123(1):37–41.

    PubMed  Google Scholar 

  114. Sekela ME, Hutchins DA, Young JB, Noon GP. Biliary surgery after cardiac transplantation. Arch Surg. 1991;126: 571–3.

    CAS  PubMed  Google Scholar 

  115. Abu-Elmagd K, Reyes J, Bond G, Mazariegos G, Wu T, Murase N, et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg. 2001;234(3):404–16. discussion 16–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  116. Ziring D, Tran R, Edelstein S, McDiarmid SV, Gajjar N, Cortina G, et al. Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplantation. 2005;79(6):702–9.

    PubMed  Google Scholar 

  117. Pinchoff RJ, Kaufman SS, Magid MS, Erdman DD, Gondolesi GE, Mendelson MH, et al. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation. 2003;76(1):183–9.

    PubMed  Google Scholar 

  118. Berho M, Torroella M, Viciana A, Weppler D, Thompson J, Nery J, et al. Adenovirus enterocolitis in human small bowel transplants. Pediatr Transplant. 1998;2(4):277–82.

    CAS  PubMed  Google Scholar 

  119. Kaufman SS, Chatterjee NK, Fuschino ME, Magid MS, Gordon RE, Morse DL, et al. Calicivirus enteritis in an intestinal transplant recipient. Am J Transplant. 2003;3(6):764–8.

    PubMed  Google Scholar 

  120. Tzakis AG. Cytomegalovirus prophylaxis with ganciclovir and cytomegalovirus immune globulin in liver and intestinal transplantation. Transpl Infect Dis. 2001;2:35–9.

    Google Scholar 

  121. Abu-Elmagd KM, Zak M, Stamos JM, Bond GJ, Jain A, Youk AO, et al. De novo malignancies after intestinal and multivisceral transplantation. Transplantation. 2004;77(11):1719–25.

    PubMed  Google Scholar 

  122. Chehade M, Nowak-Wegrzyn A, Kaufman SS, Fishbein TM, Tschernia A, LeLeiko NS. De novo food allergy after intestinal transplantation: a report of three cases. J Pediatr Gastroenterol Nutr. 2004;38(5):545–7.

    PubMed  Google Scholar 

  123. Hockenbery D, Strasser S, McDonald G. Gastrointestinal and hepatic complications. In: Appelbaum FR, Forman SJ, Negrin RS, Antin JH, editors. Thomas’ hematopoietic cell transplantation: stem cell transplantation. 5th ed. Hoboken, NJ: John Wiley & Sons Inc; 2015.

    Google Scholar 

  124. Fries BC, Riddell SR, Kim HW, Corey L, Dahlgren C, Woolfrey A, et al. Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation. Biol Blood Marrow Transplant. 2005;11(2): 136–48.

    PubMed  Google Scholar 

  125. Velasco Guardado A, Lopez-Corral L, Perez-Simon JA, Caballero-Velazquez T, Flores Corral T, Caballero Barrigon D, et al. Helicobacter pylori infection and graft-versus-host disease. Biol Blood Marrow Transplant. 2011;17(5):765–9.

    PubMed  Google Scholar 

  126. Kang G, Srivastava A, Pulimood AB, Dennison D, Chandy M. Etiology of diarrhea in patients undergoing allogeneic bone marrow transplantation in South India. Transplantation. 2002;73(8):1247–51.

    PubMed  Google Scholar 

  127. Muller CI, Zeiser R, Grullich C, Finke J, Bertz H, Schmitt-Graff A, et al. Intestinal cryptosporidiosis mimicking acute graft-versus-host disease following matched unrelated hematopoietic stem cell transplantation. Transplantation. 2004;77(9):1478–9.

    PubMed  Google Scholar 

  128. Sebastian E, Martin J, McDonald GB, Flores T, Rodriguez A, Blanco A, et al. Cryptosporidium parvum infection vs GVHD after hematopoietic SCT: diagnosis by PCR with resolution of symptoms. Bone Marrow Transplant. 2011;46(4):612–4.

    CAS  PubMed  Google Scholar 

  129. Schwartz S, Vergoulidou M, Schreier E, Loddenkemper C, Reinwald M, Schmidt-Hieber M, et al. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood. 2011; 117(22):5850–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  130. McLauchlin J, Amar CFL, Pedraza-Diaz S, Mieli-Vergani G, Hadzic N, Davies EG. Polymerase chain reaction-based diagnosis of infection with Cryptosporidium in children with primary immunodeficiencies. Pediatr Infect Dis J. 2003;22(4):329–35.

    PubMed  Google Scholar 

  131. Dimicoli S, Bensoussan D, Latger-Cannard V, Straczek J, Antunes L, Mainard L, et al. Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndrome. Bone Marrow Transplant. 2003;32(7):733–7.

    CAS  PubMed  Google Scholar 

  132. McCullough KD, McDonald GB. Neutropenic enterocolitis. Curr Treatment Option Infect Dis. 2003;5:367–75.

    Google Scholar 

  133. Davila ML. Neutropenic enterocolitis: current issues in diagnosis and management. Curr Infect Dis Rep. 2007;9(2):116–20.

    PubMed  Google Scholar 

  134. Lehrnbecher T, Marshall D, Gao C, Chanock SJ. A second look at anorectal infections in cancer patients in a large cancer institute: the success of early intervention with antibiotics and surgery. Infection. 2002;30(5):272–6.

    CAS  PubMed  Google Scholar 

  135. Ryan C, De Gascun CF, Powell C, Sheahan K, Mooney EE, McCormick A, et al. Cytomegalovirus-induced cutaneous vasculopathy and perianal ulceration. J Am Acad Dermatol. 2011;64(6):1216–8.

    PubMed  Google Scholar 

  136. Strasser SI, McDonald GB. Gastrointestinal and hepatic complications. In: Forman SJ, Appelbaum FR, Blume KG, Negrin R, editors. Thomas’ hematopoietic cell transplantation. 4th ed. Malden, MA: Blackwell Publishing Inc; 2009.

    Google Scholar 

  137. von Bahr L, Blennow O, Alm J, Bjorklund A, Malmberg KJ, Mougiakakos D, et al. Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation. Bone Marrow Transplant. 2015;50(9):1217–23.

    Google Scholar 

  138. Malone FR, Leisenring W, Schoch G, Stern J, Aker S, Lawler R, et al. Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant. Bone Marrow Transplant. 2007;40:765–72.

    CAS  PubMed  Google Scholar 

  139. Wu D, Hockenberry DM, Brentnall TA, Baehr PH, Ponec RJ, Kuver R, et al. Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients. Transplantation. 1998;66(10):1319–24.

    CAS  PubMed  Google Scholar 

  140. Weisdorf SA, Salati LM, Longsdorf JA, Ramsay NK, Sharp HL. Graft-vs-host disease of the intestine: a protein-losing enteropathy characterized by fecal alpha1-antitrypsin. Gastroenterology. 1983;85:1076–81.

    CAS  PubMed  Google Scholar 

  141. Cox GJ, Matsui SM, Lo RS, Hinds M, Bowden RA, Hackman RC, et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology. 1994;107:1398–407.

    CAS  PubMed  Google Scholar 

  142. Castilla-Llorente C, Martin PJ, McDonald GB, Storer BE, Appelbaum FR, Deeg HJ, et al. Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2014;49(7):966–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  143. Sakai M, McDonald GB. Gastrointestinal and hepatic manifestations of chronic GVHD. In: Vogelsang G, Pavletic S, editors. Chronic graft-versus-host disease principles and practice of interdisciplinary management. New York, NY: Cambridge University Press; 2008.

    Google Scholar 

  144. Parfitt JR, Jayakumar S, Driman DK. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol. 2008;32(9):1367–72.

    PubMed  Google Scholar 

  145. Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012;55(7):905–14.

    CAS  PubMed  PubMed Central  Google Scholar 

  146. Ye X, Van JN, Munoz FM, Revell PA, Kozinetz CA, Krance RA, et al. Noroviruses as a cause of diarrhea in immunocompromised pediatric hematopoietic stem cell and solid organ transplant recipients. Am J Transplant. 2015;15(7):1874–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  147. Zaia J, Baden L, Boeckh MJ, Chakrabarti S, Einsele H, Ljungman P, et al. Viral disease prevention after hematopoietic cell transplantation. Bone Marrow Transplant. 2009;44(8): 471–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  148. van Burik JH, Leisenring W, Myerson D, Hackman RC, Shulman HM, Sale GE, et al. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis: an autopsy study of 355 patients. Medicine (Baltimore). 1998;77:246–54.

    PubMed  Google Scholar 

  149. Maertens J, Marchetti O, Herbrecht R, Cornely O, Flückiger U, Frere P, et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 update. Bone Marrow Transplant. 2011;46(5):709–18.

    CAS  PubMed  Google Scholar 

  150. Ljungman P, Hakki M, Boeckh M. Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematology. 2011;25(1):151–69.

    Google Scholar 

  151. Boeckh M, Nichols WG, Chemaly RF, Papanicolaou GA, Wingard JR, Xie H, et al. Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial. Ann Intern Med. 2015;162(1):1–10.

    PubMed  PubMed Central  Google Scholar 

  152. Boeckh M, Murphy WJ, Peggs KS. Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies. Biol Blood Marrow Transplant. 2015;21(1):24–9.

    CAS  PubMed  Google Scholar 

  153. Sonsino E, Mouy R, Foucaud P, Cezard JP, Aigrain Y, Bocquet L, et al. Intestinal pseudoobstruction related to cytomegalovirus infection of myenteric plexus (letter). N Engl J Med. 1984;311:196–7.

    CAS  PubMed  Google Scholar 

  154. Baldwin A, Kingman H, Darville M, Foot AB, Grier D, Cornish JM, et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant. 2000;26(12):1333–8.

    CAS  PubMed  Google Scholar 

  155. La Rosa AM, Champlin RE, Mirza N, Gajewski J, Giralt S, Rolston KV, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis. 2001;32(6): 871–6.

    PubMed  Google Scholar 

  156. Bruno B, Gooley T, Hackman RC, Davis C, Corey L, Boeckh M. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol Blood Marrow Transplant. 2003;9(5):341–52.

    PubMed  Google Scholar 

  157. Muller WJ, Levin MJ, Shin YK, Robinson C, Quinones R, Malcolm J, et al. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis. 2005;41(12):1812–6.

    CAS  PubMed  Google Scholar 

  158. Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant. 2007;13(1):74–81.

    CAS  PubMed  Google Scholar 

  159. Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, et al. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Clin Infect Dis. 2013;57(6):794–802.

    CAS  PubMed  Google Scholar 

  160. Zutter MM, Durnam DM, Hackman RC, Loughran TPJ, Kidd PG, Ashley RL, et al. Secondary T-cell lymphoproliferation after marrow transplantation. Am J Clin Pathol. 1990;94:714–21.

    CAS  PubMed  Google Scholar 

  161. Collier AC, Miller RA, Meyers JD. Cryptosporidiosis after marrow transplantation: person-to-person transmission and treatment with spiramycin. Ann Intern Med. 1984;101:205–6.

    CAS  PubMed  Google Scholar 

  162. Bromiker R, Korman SH, Or R, Hardan I, Naparstek E, Cohen P, et al. Severe giardiasis in two patients undergoing bone marrow transplantation. Bone Marrow Transplant. 1989;4:701–3.

    CAS  PubMed  Google Scholar 

  163. McDonald GB, Sullivan KM, Schuffler MD, Shulman HM, Thomas ED. Esophageal abnormalities in chronic graft-versus-host disease in humans. Gastroenterology. 1981;80: 914–21.

    CAS  PubMed  Google Scholar 

  164. Minocha A, Mandanas RA, Kida M, Jazzar A. Bullous esophagitis due to chronic graft-versus-host disease. Am J Gastroenterol. 1997;92:529–30.

    CAS  PubMed  Google Scholar 

  165. Patey-Mariaud De Serre N, Reijasse D, Verkarre V, Canioni D, Colomb V, Haddad E, et al. Chronic intestinal graft-versus-host disease: clinical, histological and immunohistochemical analysis of 17 children. Bone Marrow Transplant. 2002;29:223–30.

    CAS  PubMed  Google Scholar 

  166. Akpek G, Chinratanalab W, Lee LA, Torbenson M, Hallick JP, Anders V, et al. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol Blood Marrow Transpl. 2003;1:46–51.

    Google Scholar 

  167. Yuen KY, Woo PC, Liang RH, Chiu EK, Chen FF, Wong SS, et al. Clinical significance of alimentary tract microbes in bone marrow transplant recipients. Diagn Microbiol Infect Dis. 1998;30(2):75–81.

    CAS  PubMed  Google Scholar 

  168. Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K, et al. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplant. 2005;36:115–21.

    CAS  PubMed  Google Scholar 

  169. Borgaonkar MR, Duggan PR, Adams G. Differing clinical manifestations of celiac disease transmitted by bone marrow transplantation. Dig Dis Sci. 2006;51(1):210–2.

    PubMed  Google Scholar 

  170. Sonwalkar SA, James RM, Ahmad T, Zhang L, Verbeke CS, Barnard DL, et al. Fulminant Crohn’s colitis after allogeneic stem cell transplantation. Gut. 2003;52(10):1518–21.

    CAS  PubMed  PubMed Central  Google Scholar 

  171. Akpek G, Valladares JL, Lee L, Margolis J, Vogelsang GB. Pancreatic insufficiency in patients with chronic graft-versus-host disease. Bone Marrow Transplant. 2001;27:163–6.

    CAS  PubMed  Google Scholar 

  172. Vindigni SM, Surawicz CM. The gut microbiome: a clinically significant player in transplantation? Expert Rev Clin Immunol. 2015;11(7):781–3.

    CAS  PubMed  Google Scholar 

  173. Grat M, Holowko W, Galecka M, Grat K, Szachtaz P, Lewandowsk Z, et al. Gut microbiota in cirrhotic liver transplant candidates. Hepatogastroenterology. 2014;61(134):1661–7.

    PubMed  Google Scholar 

  174. Chassaing B, Etienne-Mesmin L, Gewirtz AT. Microbiota-liver axis in hepatic disease. Hepatology. 2014;59(1):328–39.

    CAS  PubMed  Google Scholar 

  175. Rai R, Saraswat VA, Dhiman RK. Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol. 2015;5 Suppl 1:S29–36.

    PubMed  Google Scholar 

  176. Zhang Y, Chen J, Wu J, Chalson H, Merigan L, Mitchell A. Probiotic use in preventing postoperative infection in liver transplant patients. Hepatobiliary Surg Nutr. 2013;2(3): 142–7.

    PubMed  PubMed Central  Google Scholar 

  177. Lee JR, Muthukumar T, Dadhania D, Taur Y, Jenq RR, Toussaint NC, et al. Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS One. 2015;10(3):e0122399.

    PubMed  PubMed Central  Google Scholar 

  178. Bartman C, Chong AS, Alegre ML. The influence of the microbiota on the immune response to transplantation. Curr Opin Organ Transplant. 2015;20(1):1–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  179. Holler E, Butzhammer P, Schmid K, Hundsrucker C, Koestler J, Peter K, et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20(5):640–5.

    PubMed  PubMed Central  Google Scholar 

  180. Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun. 2008;76(10):4726–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  181. Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124(7):1174–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  182. Jenq RR, Ubeda C, Taur Y, Menezes CC, Khanin R, Dudakov JA, et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med. 2012;209(5):903–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  183. Sekirov I, Finlay BB. The role of the intestinal microbiota in enteric infection. J Physiol. 2009;587(17):4159–67.

    CAS  PubMed  PubMed Central  Google Scholar 

  184. Kuhn KA, Pedraza I, Demoruelle MK. Mucosal immune responses to microbiota in the development of autoimmune disease. Rheum Dis Clin N Am. 2014;40(4):711–25.

    Google Scholar 

  185. Baehr PH, McDonald GB. Esophageal infections: risk factors, presentation, diagnosis, and treatment. Gastroenterology. 1994;106:509–32.

    CAS  PubMed  Google Scholar 

  186. Rubin RH. Gastrointestinal infectious disease complications following transplantation and their differentiation from immunosuppressant-induced gastrointestinal toxicities. Clin Transplant. 2001;4:11–22.

    Google Scholar 

  187. Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis. 1997;24:369–74.

    CAS  PubMed  Google Scholar 

  188. Anderson LI, Frederiksen HJ, Appleyard M. Prevalence of esophageal Candida colonization in a Danish population, with special reference to esophageal symptoms, benign esophageal disorders, and pulmonary disease. J Infect Dis. 1992;165:389.

    Google Scholar 

  189. Hackman RC, Wolford JL, Gleaves CA, Myerson D, Beauchamp MD, Meyers JD, et al. Recognition and rapid diagnosis of upper gastrointestinal cytomegalovirus infection in marrow transplant recipients. A comparison of seven virologic methods. Transplantation. 1994;57:231–7.

    CAS  PubMed  Google Scholar 

  190. Walsh TJ, Belitsos NJ, Hamilton SR. Bacterial esophagitis in immunocompromised patients. Arch Intern Med. 1986;146: 1345–9.

    CAS  PubMed  Google Scholar 

  191. Gordon AH, Marshall JB. Esophageal tuberculosis: definitive diagnosis by endoscopy. Am J Gastroenterol. 1990;85:174.

    CAS  PubMed  Google Scholar 

  192. Augustine SM, Yeo CJ, Buchman TG, Achuff SC, Baumgartner WA. Gastrointestinal complications in heart and in heart-lung transplant patients. J Heart Lung Transpl. 1991;10(4):547–55. discussion 55–6.

    CAS  Google Scholar 

  193. Reed EC, Wolford JL, Kopecky KJ, Lilleby KE, Dandliker PS, Todaro JL, et al. Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial. Ann Intern Med. 1990;112: 505–10.

    CAS  PubMed  Google Scholar 

  194. Yagi T, Karasuno T, Hasegawa T, Yasumi M, Kawamoto S, Murakami M, et al. Acute abdomen without cutaneous signs of varicella zoster virus infection as a late complication of allogeneic bone marrow transplantation: importance of empiric therapy with acyclovir. Bone Marrow Transplant. 2000;25(9):1003–5.

    CAS  PubMed  Google Scholar 

  195. Arabia FA, Rosado LJ, Huston CL, Sethi GK, Copeland III JG. Incidence and recurrence of gastrointestinal cytomegalovirus infection in heart transplantation. Ann Thorac Surg. 1993;55:8–11.

    CAS  PubMed  Google Scholar 

  196. Smith DM, Agura E, Netto G, Collins R, Levy M, Goldstein R, et al. Liver transplant-associated graft-versus-host disease. Transplantation. 2003;75(1):118–26.

    CAS  PubMed  Google Scholar 

  197. Assi MA, Pulido JS, Peters SG, McCannel CA, Razonable RR. Graft-vs.-host disease in lung and other solid organ transplant recipients. Clin Transplant. 2007;21(1):1–6.

    PubMed  Google Scholar 

  198. Gulbahce HE, Brown CA, Wick M, Segall M, Jessurun J. Graft-vs-host disease after solid organ transplant. Am J Clin Pathol. 2003;119(4):568–73.

    PubMed  Google Scholar 

  199. Ponec RJ, Hackman RC, McDonald GB. Endoscopic and histologic diagnosis of intestinal graft-vs.-host disease after marrow transplantation. Gastrointest Endosc. 1999;49:612–21.

    CAS  PubMed  Google Scholar 

  200. Holmberg L, Kikuchi K, Gooley TA, Adams KM, Hockenbery DM, Flowers MED, et al. Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome. Biol Blood Marrow Transpl. 2006;12(2):226–34.

    Google Scholar 

  201. Spencer GD, Hackman RC, McDonald GB, Amos DE, Cunningham BA, Meyers JD, et al. A prospective study of unexplained nausea and vomiting after marrow transplantation. Transplantation. 1986;42:602–7.

    CAS  PubMed  Google Scholar 

  202. Eagle DA, Gian V, Lauwers GY, Manivel JC, Moreb JS, Mastin S, et al. Gastroparesis following bone marrow transplantation. Bone Marrow Transplant. 2001;28(1):59–62.

    CAS  PubMed  Google Scholar 

  203. Brand RE, DiBaise JK, Quigley EM, Gobar LS, Harmon KS, Lynch JC, et al. Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation. Lancet. 1998;352(9145):1985. see comments.

    CAS  PubMed  Google Scholar 

  204. DiBaise JK, Lyden E, Tarantolo SR, Bierman PJ, Brand RE. A prospective study of gastric emptying and its relationship to the development of nausea, vomiting, and anorexia after autologous stem cell transplantation. Am J Gastroenterol. 2005;100(7):1571–7.

    PubMed  Google Scholar 

  205. Pescovitz MD, Navarro MT. Immunosuppressive therapy and post-transplantation diarrhea. Clin Transplant. 2001;4:23–8.

    Google Scholar 

  206. Rampling A, Warren RE, Berry PJ, Swirsky D, Hoggarth CE, Bevan PC. Atypical Clostridium difficile colitis in neutropenic patients (letter). Lancet. 1982;2:162–3.

    CAS  PubMed  Google Scholar 

  207. Gorschluter M, Glasmacher A, Hahn C, Schakowski F, Ziske C, Molitor E, et al. Clostridium difficile infection in patients with neutropenia. Clin Infect Dis. 2001;33(6):786–91.

    CAS  PubMed  Google Scholar 

  208. Gellad ZF, Alexander BD, Liu JK, Griffith BC, Meyer AM, Johnson JL, et al. Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients. Transpl Infect Dis. 2007;9(4):276–80.

    CAS  PubMed  Google Scholar 

  209. Keven K, Basu A, Re L, Tan H, Marcos A, Fung JJ, et al. Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl Infect Dis. 2004;6(1):10–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  210. Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer. 2000;8(6): 504–5.

    CAS  PubMed  Google Scholar 

  211. Dubberke ER, Gerding DN, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S81–92.

    PubMed  Google Scholar 

  212. Muto CA, Blank MK, Marsh JW, Vergis EN, O'Leary MM, Shutt KA, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach. Clin Infect Dis. 2007;45(10):1266–73.

    PubMed  Google Scholar 

  213. Bhatt AS, Freeman SS, Herrera AF, Pedamallu CS, Gevers D, Duke F, et al. Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome. N Engl J Med. 2013;369(6): 517–28.

    CAS  PubMed  PubMed Central  Google Scholar 

  214. Gorkiewicz G, Trajanoski S, Hogenauer C. Bradyrhizobium enterica in cord colitis syndrome. N Engl J Med. 2013;369(19):1866–7.

    CAS  PubMed  Google Scholar 

  215. Herrera AF, Soriano G, Bellizzi AM, Hornick JL, Ho VT, Ballen KK, et al. Cord colitis syndrome in cord-blood stem-cell transplantation. N Engl J Med. 2011;365(9):815–24.

    CAS  PubMed  Google Scholar 

  216. Gupta NK, Masia R. Cord colitis syndrome: a cause of granulomatous inflammation in the upper and lower gastrointestinal tract. Am J Surg Pathol. 2013;37(7):1109–13.

    PubMed  PubMed Central  Google Scholar 

  217. Matuchansky C. Cord colitis syndrome in cord-blood stem-cell transplantation. N Engl J Med. 2011;365(24):2336–7. author reply 7–8.

    CAS  PubMed  Google Scholar 

  218. Milano F, Shulman HM, Guthrie KA, Riffkin I, McDonald GB, Delaney C. Late-onset colitis after cord blood transplantation is consistent with graft-versus-host disease: results of a blinded histopathological review. Biol Blood Marrow Transplant. 2014;20(7):1008–13.

    PubMed  Google Scholar 

  219. Anonymous. Clostridium septicum infection and neutropenic enterocolitis (editorial). Lancet. 1987;2:608.

    Google Scholar 

  220. Cordonnier C, Martino R, Trabasso P, Held TK, Akan H, Ward MS, et al. Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients. Clin Infect Dis. 2004;38(9):1229–36.

    CAS  PubMed  Google Scholar 

  221. Nicholson O, Feja K, LaRussa P, George D, Unal E, Della Latta P, et al. Nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplant recipients: case report and review of the literature. Pediatr Infect Dis J. 2006;25(3):263–7.

    PubMed  Google Scholar 

  222. Fang GD, Yu VL, Vickers RM. Disease due to the Legionellaceae (other than Legionella pneumophila). Historical, microbiological, clinical, and epidemiological review. [erratum appears in Medicine (Baltimore) 1989;68(4):209].

    Google Scholar 

  223. Spencer GD, Shulman HM, Myerson D, Thomas ED, McDonald GB. Diffuse intestinal ulceration after marrow transplantation: a clinical-pathological study of 13 patients. Hum Pathol. 1986;17:621–33.

    CAS  PubMed  Google Scholar 

  224. Tajima T. An autopsy case of primary cytomegalic inclusion enteritis with remarkable hypoproteinemia. Acta Pathol Jpn. 1974;24:151–62.

    CAS  PubMed  Google Scholar 

  225. Underwood JCE, Corbett CL. Persistent diarrhea and hypoalbuminemia associated with cytomegalovirus enteritis. Br Med J. 1978;1:1029–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  226. Remzi FH. Colonic complications of organ transplantation. Transplant Proc. 2002;34(6):2119–21.

    CAS  PubMed  Google Scholar 

  227. Lewis-Jones HG, Ward RG, Garvey C. Cytomegalovirus infection masquerading as colonic neoplasia. Br J Radiol. 1990;63:573–4.

    CAS  PubMed  Google Scholar 

  228. van Burik JA, Lawatsch EJ, DeFor TE, Weisdorf DJ. Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transpl. 2001;7(12): 674–9.

    Google Scholar 

  229. Fishman JA, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt HJ, et al. Cytomegalovirus in transplantation—challenging the status quo. Clin Transplant. 2007;21(2): 149–58.

    PubMed  Google Scholar 

  230. Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med. 1985;312: 529–33.

    CAS  PubMed  Google Scholar 

  231. Walls T, Shankar AG, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis. 2003;3(2):79–86.

    PubMed  Google Scholar 

  232. Michaels MG, Green M, Wald ER, Starzl TE. Adenovirus infection in pediatric liver transplant recipients. J Infect Dis. 1992;165:170–4.

    CAS  PubMed  Google Scholar 

  233. Lion T, Kosulin K, Landlinger C, Rauch M, Preuner S, Jugovic D, et al. Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation. Leukemia. 2010;24(4):706–14.

    CAS  PubMed  Google Scholar 

  234. Anderson EJ, Guzman-Cottrill JA, Kletzel M, Thormann K, Sullivan C, Zheng X, et al. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. Pediatr Transplant. 2008;12(2):219–27.

    CAS  PubMed  Google Scholar 

  235. Leruez-Ville M, Chardin-Ouachee M, Neven B, Picard C, Le Guinche I, Fischer A, et al. Description of an adenovirus A31 outbreak in a paediatric haematology unit. Bone Marrow Transplant. 2006;38(1):23–8.

    CAS  PubMed  Google Scholar 

  236. Mattner F, Sykora KW, Meissner B, Heim A. An adenovirus type F41 outbreak in a pediatric bone marrow transplant unit: analysis of clinical impact and preventive strategies. Pediatr Infect Dis J. 2008;27(5):419–24.

    PubMed  Google Scholar 

  237. Ljungman P. Treatment of adenovirus infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis. 2004;23(8):583–8.

    CAS  PubMed  Google Scholar 

  238. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface. Bone Marrow Transplant. 2009;44(8):453–5.

    CAS  PubMed  Google Scholar 

  239. Humar A, Kumar D, Mazzulli T, Razonable RR, Moussa G, Paya CV, et al. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant. 2005;5(10):2555–9.

    PubMed  Google Scholar 

  240. Willoughby RE, Wee SB, Yolken RH. Non-group A rotavirus infection associated with severe gastroenteritis in a bone marrow tranplant patient. Pediatr Infect Dis J. 1988;7:133–5.

    CAS  PubMed  Google Scholar 

  241. Sebire NJ, Malone M, Shah N, Anderson G, Gaspar HB, Cubitt WD. Pathology of astrovirus associated diarrhoea in a paediatric bone marrow transplant recipient. J Clin Pathol. 2004;57(9):1001–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  242. Rodriguez-Baez N, O'Brien R, Qiu SQ, Bass DM. Astrovirus, adenovirus, and rotavirus in hospitalized children: prevalence and association with gastroenteritis. J Pediatr Gastroenterol Nutr. 2002;35(1):64–8.

    PubMed  Google Scholar 

  243. Kamboj M, Mihu CN, Sepkowitz K, Kernan NA, Papanicolaou GA. Work-up for infectious diarrhea after allogeneic hematopoietic stem cell transplantation: single specimen testing results in cost savings without compromising diagnostic yield. Transpl Infect Dis. 2007;9(4):265–9.

    CAS  PubMed  Google Scholar 

  244. Liakopoulou E, Mutton K, Carrington D, Robinson S, Steward CG, Goulden NJ, et al. Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation. Bone Marrow Transplant. 2005;36(8):691–4.

    CAS  PubMed  Google Scholar 

  245. Stelzmueller I, Wiesmayr S, Swenson BR, Biebl M, Goegele H, Margreiter R, et al. Rotavirus enteritis in solid organ transplant recipients: an underestimated problem? Transpl Infect Dis. 2007;9(4):281–5.

    CAS  PubMed  Google Scholar 

  246. Fitts SW, Green M, Reyes J, Nour B, Tzakis AG, Kocoshis SA. Clinical features of nosocomial rotavirus infection in pediatric liver transplant recipients. Clin Transplant. 1995;9(3 Pt 1):201–4.

    CAS  PubMed  Google Scholar 

  247. Stelzmueller I, Dunst KM, Hengster P, Wykypiel H, Steurer W, Wiesmayr S, et al. A cluster of rotavirus enteritis in adult transplant recipients. Transpl Int. 2005;18(4):470–4.

    CAS  PubMed  Google Scholar 

  248. Mattner F, Sohr D, Heim A, Gastmeier P, Vennema H, Koopmans M. Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect. 2006;12(1):69–74.

    CAS  PubMed  Google Scholar 

  249. Kaufman SS, Chatterjee NK, Fuschino ME, Morse DL, Morotti RA, Magid MS, et al. Characteristics of human calicivirus enteritis in intestinal transplant recipients. J Pediatr Gastroenterol Nutr. 2005;40(3):328–33.

    PubMed  Google Scholar 

  250. Danna PL, Urban C, Bellin E, Rahal JJ. Role of candida in pathogenesis of antibiotic-associated diarrhea in elderly patients. Lancet. 1991;337:511–4.

    CAS  PubMed  Google Scholar 

  251. Prescott RJ, Harris M, Banerjee SS. Fungal infections of the small and large intestine. J Clin Pathol. 1992;45:806–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  252. Pinto-Marques P, Hockenbery DM, Hackman RC, Tapper D, McDonald GB. Successful medical treatment of intestinal ulceration caused by Rhizopus microsporus. Bone Marrow Transplant. 2003;32(7):739–40.

    CAS  PubMed  Google Scholar 

  253. Sing A, Tybus K, Heesemann J, Mathis A. Molecular diagnosis of an Enterocytozoon bieneusi human genotype C infection in a moderately immunosuppressed human immunodeficiency virus seronegative liver-transplant recipient with severe chronic diarrhea. J Clin Microbiol. 2001;39(6):2371–2. Review [5 refs].

    CAS  PubMed  PubMed Central  Google Scholar 

  254. Goetz M, Eichenlaub S, Pape GR, Hoffmann RM. Chronic diarrhea as a result of intestinal microsporidiosis in a liver transplant recipient. Transplantation. 2001;71(2):334–7.

    CAS  PubMed  Google Scholar 

  255. Rabodonirina M, Bertocchi M, Desportes-Livage I, Cotte L, Levrey H, Piens MA, et al. Enterocytozoon bieneusi as a cause of chronic diarrhea in a heart-lung transplant recipient who was seronegative for human immunodeficiency virus. Clin Infect Dis. 1996;23(1):114–7. see comments.

    CAS  PubMed  Google Scholar 

  256. Guerard A, Rabodonirina M, Cotte L, Liguory O, Piens MA, Daoud S, et al. Intestinal microsporidiosis occurring in two renal transplant recipients treated with mycophenolate mofetil. Transplantation. 1999;68(5):699–707.

    CAS  PubMed  Google Scholar 

  257. Mittal N, Thompson JF, Kato T, Tzakis AG. Tacrolimus and diarrhea: pathogenesis of altered metabolism. Pediatr Transplant. 2001;5(2):75–9. letter; comment.

    CAS  PubMed  Google Scholar 

  258. Eades SK, Boineau FG, Christensen ML. Increased tacrolimus levels in a pediatric renal transplant patient attributed to chronic diarrhea. Pediatr Transplant. 2000;4(1):63–6.

    CAS  PubMed  Google Scholar 

  259. Hardinger KL, Hebbar S, Bloomer T, Murillo D. Adverse drug reaction driven immunosuppressive drug manipulations: a single-center comparison of enteric-coated mycophenolate sodium vs. mycophenolate mofetil. Clin Transplant. 2008;22: 555–61.

    PubMed  Google Scholar 

  260. Kaplan B, Meier-Kriesche HU, Jacobs MG, Friedman G, Bonomini L, DeFranco P, et al. Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal pain. Am J Kidney Dis. 1999;34(1):65–8.

    CAS  PubMed  Google Scholar 

  261. Hoekstra HJ, Hawkins K, de Boer WJ, Rottier K, van der Bij W. Gastrointestinal complications in lung transplant survivors that require surgical intervention. Br J Surg. 2001;88(3):433–8.

    CAS  PubMed  Google Scholar 

  262. Zainudin BM, Kassim F, Annuar NM, Lim CS, Ghazali AK, Murad Z. Disseminated histoplasmosis presenting with ileal perforation in a renal transplant recipient. J Trop Med Hygiene. 1992;95:276–9.

    CAS  Google Scholar 

  263. Dominguez Fernandez E, Albrecht KH, Heemann U, Kohnle M, Erhard J, Stoblen F, et al. Prevalence of diverticulosis and incidence of bowel perforation after kidney transplantation in patients with polycystic kidney disease. Transpl Int. 1998;11(1):28–31.

    CAS  PubMed  Google Scholar 

  264. Nomdedeu JF, Nomdedeu J, Martino R, Bordes R, Portorreal R, Sureda A, et al. Ogilvie’s syndrome from disseminated varicella-zoster infection and infarcted celiac ganglia. J Clin Gastroenterol. 1995;20:157–9.

    CAS  PubMed  Google Scholar 

  265. Grant RM, Weitzman SS, Sherman CG, Sirkin WL, Petric M, Tellier R. Fulminant disseminated Varicella Zoster virus infection without skin involvement. J Clin Virol. 2002;24(1–2):7–12.

    PubMed  Google Scholar 

  266. Yong S, Attal H, Chejfec G. Pseudomembranous gastritis: a novel complication of Aspergillus infection in a patient with a bone marrow transplant and graft versus host disease. Arch Pathol Lab Med. 2000;124(4):619–24.

    CAS  PubMed  Google Scholar 

  267. Cartoni C, Dragoni F, Micozzi A, Pescarmona E, Mecarocci S, Chirletti P, et al. Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography. J Clin Oncol. 2001;19(3):756–61.

    CAS  PubMed  Google Scholar 

  268. Schlatter M, Snyder K, Freyer D. Successful nonoperative management of typhlitis in pediatric oncology patients. J Pediatr Surg. 2002;37(8):1151–5.

    PubMed  Google Scholar 

  269. Baerg J, Murphy JJ, Anderson R, Magee JF. Neutropenic enteropathy: a 10-year review. J Pediatr Surg. 1999; 34(7):1068–71.

    CAS  PubMed  Google Scholar 

  270. Wahbeh G, Hupertz V, Hallowell S, Patel R, Chrisant MR. Idiopathic colitis following cardiac transplantation: three pediatric cases. Pediatr Transplant. 2003;7(6):464–8.

    PubMed  Google Scholar 

  271. Knechtle SJ, Davidoff AM, Rice RP. Pneumatosis intestinalis. Surgical management and clinical outcome. Ann Surg. 1990;212:160–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  272. Glenn J, Cotton D, Wesley R, Pizzo P. Anorectal infections in patients with malignant disease. Rev Infect Dis. 1988;16: 42–52.

    Google Scholar 

  273. Corfitsen MT, Hansen CP, Christensen TH, Kaae HH. Anorectal abscesses in immunosuppressed patients. Eur J Surg. 1992;158(1):51–3.

    CAS  PubMed  Google Scholar 

  274. Kalb RE, Grossman ME. Chronic perianal herpes simplex in immunocompromised hosts. Am J Med. 1986;80:486–90.

    CAS  PubMed  Google Scholar 

  275. Schwartz JM, Wolford JL, Thornquist MD, Hockenbery DM, Murakami CS, Drennan F, et al. Severe gastrointestinal bleeding after marrow transplantation, 1987-1997: incidence, causes, and outcome. Am J Gastroenterol. 2001;96:385–93.

    CAS  PubMed  Google Scholar 

  276. Dummer JS, White LT, Ho M, Griffith BP, Hardesty RL, Bahnson HT. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis. 1985;152(6):1182–91.

    CAS  PubMed  Google Scholar 

  277. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med. 1987;106(2):209–16.

    CAS  PubMed  Google Scholar 

  278. In: Kahan BD, Ponticelli C, editors. 1 ed., London: Martin Dunitz Ltd.; 2000.

    Google Scholar 

  279. Rattner HM, Cooper DJ, Zaman MB. Severe bleeding from herpes esophagitis. Am J Gastroenterol. 1985;80:523.

    CAS  PubMed  Google Scholar 

  280. Stylianos S, Chen MH, Treat MR, LoGerfo P, Rose EA. Colonic lymphoma as a cause of massive rectal bleeding in a cardiac transplant recipient. J Cardiovasc Surg. 1990;31: 315–7.

    CAS  Google Scholar 

  281. Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood. 1988;72:520–9.

    CAS  PubMed  Google Scholar 

  282. Kornbluth AA, Danzig JB, Bernstein LH. Clostridium septicum infection and associated malignancy. Report of 2 cases and review of the literature. Medicine (Baltimore). 1989;68:30–7.

    CAS  PubMed  Google Scholar 

  283. Nevo S, Swan V, Enger C. Acute bleeding after bone marrow transplantation (BMT)-incidence and effect on survival. A quantitative analysis in 1402 patients. Blood. 1998;91: 1469–77.

    CAS  PubMed  Google Scholar 

  284. Selinger RRE, McDonald GB, Hockenbery DM, Steinbach G, Kimmey MB. Efficacy of neodymium: YAG laser therapy for gastric antral vascular ectasia (GAVE) following hematopoietic cell transplant. Bone Marrow Transplant. 2006;37(2): 191–7.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology/Hepatology Section, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA, USA

    Christopher J. Damman M.A., M.D.

  2. Professor of Medicine, University of Washington Member, Gastroenterology/Hepatology Section, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    George B. McDonald M.D.

  3. Seattle Cancer Care Alliance, University of Washington Medical Center, Seattle, WA, USA

    George B. McDonald M.D.

  4. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    George B. McDonald M.D.

  5. Department of Medicine, Gastroenterology/Hepatology Section (D5-114), Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, 1100 Fairview Avenue North, Seattle, WA, 98109-1024, USA

    George B. McDonald M.D.

Authors
  1. Christopher J. Damman M.A., M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George B. McDonald M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

    Per Ljungman

  2. Tufts University School of Medicine Tufts Medical Center, Boston, MA, USA

    David Snydman

  3. University of Washington Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    Michael Boeckh

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Damman, C.J., McDonald, G.B. (2016). Gastrointestinal Infections After Solid Organ or Hematopoietic Cell Transplantation. In: Ljungman, P., Snydman, D., Boeckh, M. (eds) Transplant Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-28797-3_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28797-3_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28795-9

  • Online ISBN: 978-3-319-28797-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation